TY  - GEN
AU  - Sabnani,I
AU  - Zucker,M J
AU  - Rosenstein,E D
AU  - Baran,D A
AU  - Arroyo,L H
AU  - Tsang,P
AU  - Zubair,M
AU  - Rivera,V
TI  - A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
SN  - 1462-0332
PY  - 2009///0225
KW  - Adult
KW  - Benzamides
KW  - Cyclophosphamide
KW  - adverse effects
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Imatinib Mesylate
KW  - Immunosuppressive Agents
KW  - Lung Diseases, Interstitial
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyrimidines
KW  - Scleroderma, Systemic
KW  - complications
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1093/rheumatology/ken369
ER  -